Background {#Sec1}
==========

The incidence of postoperative nausea and vomiting (PONV) due to perioperative blood ingestion (PBI) in nasal surgery (NS) has been observed in the 34--60% of the patients \[[@CR1]--[@CR3]\]. Blood is described as a potent emetic \[[@CR4]\], and the incidence of PONV has been reduced with pharyngeal packing (PP) in NS \[[@CR5]--[@CR7]\]. However, a recent study indicated that there is no need to place PP to prevent PONV in NS \[[@CR8]\], while in theory, PP may prevent PONV by preventing PBI \[[@CR9]\].

The aim of this study was to examine the effect of PP on the perioperative gastric volume (GV) by ultrasound and our hypothesis was that the reduction of PBI with PP would reduce the PONV incidence.

Methods {#Sec2}
=======

Study design and participants {#Sec3}
-----------------------------

The Bagcilar Training and Research Hospital Non-Interventional Clinical Trials Ethics Committee approved this study (2016/450). All participants were informed about the study protocol and provided written consent for study participation.

With the Sample Size Calculation; 5% for error, 8% power and standard impact size: 0.53, *n* = 27 cases were found sufficiently for each group. We started the study with 120 (60 + 60) patients.

Patients aged \> 18 years with body mass indexes \< 35 kg/m^2^ and with an American Society of Anesthesiologists physical status classification of I or II, underwent an elective NS \[septoplasty, septo-rhinoplasty (SRP) and functional endoscopic sinus surgery (FESS)\] under general anaesthesia after an 8 h preoperative fasting. The exclusion criteria were an emergent need for surgery; risk of an increased residual GV due to pregnancy, smoking, or diabetes; upper gastrointestinal system disease; and a history of oesophageal or upper gastrointestinal surgery. The patients were randomised to receive PP (group 2) or no PP (group 1). The flow of the patient enrolment is illustrated in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Diagram of study flow. SRP, seprorhinoplasty; FESS, functional endoscopic sinus

The study was actualized from December 2016 to June 2017.

Procedure {#Sec4}
---------

Each patient was taken to the preoperative unit, and peripheral vascular access was established by a 20-G intravenous cannula. The patient was administered an intravenous infusion of 0.9% NaCl (4 ml/kg/h). None of the patients were given any analgesic or sedative drug as premedication.

A preoperative ultrasonographic examination was performed, and then each patient was anaesthetised with fentanyl (1 μg/kg), propofol (2--2.5 mg/kg) and rocuronium (0.6 mg/kg). The same anaesthesiologist performed a laryngoscopy and an intubation for all patients. Following the orotracheal intubation, soft wet pharyngeal packs were placed with gentle manoeuvres to avoid damage to the soft palate in patients in group 2. The end of the pharyngeal pack was fixed to the cheek with fastening bands such that it could be seen clearly. Patients were not administered prokinetic drugs in the perioperative period. Patients in both groups were intravenously administered ranitidine (0.5 mg/kg) following the intubation, and tenoxicam (20 mg) and tramadol (1 mg/kg) at the end of the operation for postoperative analgesia.

After the completion of the postoperative ultrasonographic evaluation, the pharyngeal packs of the patients in group 2 were removed with the gentle removal of the fastening bands. Each patient was intravenously administered 0.5 mg atropine and 1.5 mg neostigmine. Patients underwent postoperative extubation in the operating room and were taken to the postoperative care unit. After achieving a Modified Aldrete Recovery Score of 9, the patients were transferred to the ward.

Data collection and assessments {#Sec5}
-------------------------------

The operation type and duration, and the demographic characteristics of each patient were recorded. In two separate sessions (before anaesthesia induction and before postoperative extubation; Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}), an experienced radiologist with no knowledge of the group assignment and an anaesthesiologist, evaluated the stomach from the antrum by abdominal ultrasonography using a 2--5-MHz convex probe and a Shenzhen® Wed-380 system (China). Images of the stomach in a resting state were acquired between two peristaltic periods with the patient in the supine position. The postoperative examination visualised the epigastric region on the parasagittal plane. Three images were acquired from each session, and the mean antero-posterior (AP) and cranio-caudal (CC) diameters of the gastric antrum (in millimetres) were calculated. Then, the ACSA was calculated using the formula CSA = (AP × CC × 3.14) / 4 \[[@CR10]\]. The total volume of the stomach was then estimated using a previously tested and validated mathematical model with the following formula: GV (in millilitres) = 27 + 14.6 × CSA (in square millimetres) -- 1.28 × age \[[@CR11]\].Fig. 2Ultrasound image of the gastric antrum (epigastric region) in the parasagittal plane, obtained after 8 h fasting in the preoperative periodFig. 3Ultrasound image of the gastric antrum (epigastric region) in the parasagittal plane, obtained in the postoperative period

For the comparison of PONV incidence and severity in groups 1 and 2, Kortilla's scale \[[@CR12]\] was used: no PONV; absence of any emetic episode and nausea, mild PONV; mild nausea or one emetic episode or short-lasting (\~ 10 min) nausea of any severity triggered by an exogenous stimulus (e.g. drinking, eating or postoperative movement) followed by diminished nausea and the patient's feeling well throughout the entire observation period with no antiemetic drug requirement, moderate PONV; one or two emetic episodes or moderate or severe nausea without exogenous stimulus or single requirement for antiemetic therapy, and severe PONV; more than two emetic or moderate to severe nauseous episodes requiring at least one antiemetic administration \[[@CR13]\].

Statistical analysis {#Sec6}
--------------------

Statistical analyses were conducted using the 2007 Number Cruncher Statistical System software package (UT, USA). Descriptive statistics (means and standard deviations) were calculated. For normally distributed variables, a one-way analysis of variance was used to examine the differences between time points, and Tukey's multiple comparison test was used to examine differences between the groups. The unpaired *t* test was used to analyse differences between the groups, and the paired *t* test was used for a comparison of repeated measurements. For non-normally distributed variables, the Kruskal--Wallis test was used for the comparison between the time points and Dunn's multiple comparison test was used to examine the differences between the subgroups. The Mann--Whitney *U* test was used to examine the differences between the groups. Qualitative data were examined using the chi-squared test, and correlations between the variables were examined using the Pearson correlation analysis. *P* values \< 0.05 were considered to be significant.

Results {#Sec7}
=======

Data from 88 patients (*n* = 44/group) were analysed in this study. Eight patients (four from each group) were excluded because ultrasonographic evaluation prior to extubation could not be performed due to severe gas. Four additional patients (two from each group) were excluded because postoperative gastric antrum imaging could not be performed due to the superposition of the transverse column. The demographic and surgical characteristics of the study sample are presented in Table [1](#Tab1){ref-type="table"}.Table 1Demographic and surgical characteristics of the study groupsCharacteristicGroup 1 (*n* = 44)Group 2 (*n* = 44)*p*Age (years)30.18 ± 8.9832.36 ± 10.20.285Sex0.658 Male29 (65.91)27 (61.36) Female15 (34.09)17 (38.64) Weight (kg)69.24 ± 12.6475.05 ± 20.20.110 Height (cm)169.34 ± 9.76166.14 ± 17.770.297 BMI (kg/m^2^)24.28 ± 4.1325.57 ± 4.50.164ASA physical status0.368 I31 (70.45)27 (61.36) II13 (29.55)17 (38.64)Surgery duration (min)100.91 ± 48.0292.27 ± 39.540.360Surgery type0.251 Septoplasty15 (34.09)16 (36.36) Septo-rhinoplasty25 (56.82)19 (43.18) FESS4 (9.09)9 (20.45)Data are presented as mean ± standard deviation or *n* (%)*BMI* body mass index, *ASA* American Society of Anesthesiologists, *FESS* functional endoscopic sinus surgery

In groups 1 and 2, AP and CC diameters, as well as ACSAs, were significantly larger in the postoperative period than in the preoperative period (all *p* \< 0.05). Postoperative AP and CC diameters and ASCAs were greater in group 1 than in group 2 (all *p* \< 0.05; Table [2](#Tab2){ref-type="table"}). In patients undergoing SRP and FESS, postoperative AP diameters were greater than preoperative AP diameters (both *p* \< 0.05); no significant difference in this variable was observed in patients undergoing a septoplasty. The postoperative CC diameter and ACSA were significantly greater than preoperatively in patients undergoing SRP (both *p* \< 0.05), whereas no difference in these values was observed among patients undergoing a septoplasty and FESS (Table [3](#Tab3){ref-type="table"}).Table 2Ultrasonographically obtained gastric antrum dataVariableGroup 1 (*n* = 44)Group 2 (*n* = 44)*p*Pre AP diameter (mm)14.82 ± 3.3615.25 ± 3.720.569Post AP diameter (mm)19.34 ± 5.9317 ± 4.760.044*p*0.00010.003Pre CC diameter (mm)24.05 ± 4.8721.66 ± 5.310.031Post CC diameter (mm)29.09 ± 8.3723.45 ± 6.450.001*p*0.00010.032Pre ACSA (mm^2^)280.06 ± 87.16266.16 ± 109.250.511Post ACSA (mm^2^)463.17 ± 257.79324.83 ± 155.540.003*p*0.00010.005Pre--Post AP diameter difference (%)18.38 ± 24.487.56 ± 17.60.019Pre--Post CC diameter difference (%)13.39 ± 20.065.16 ± 19.080.052Pre--Post ACSA difference (%)27.26 ± 30.4410.96 ± 25.160.007Pre--Post ACSA difference (mm^2^)183.11 ± 248.4558.56 ± 131.790.004Data are presented as the mean ± standard deviation*Pre* preoperative, *AP* antero-posterior, *Post* postoperative, *CC* cranio-caudal, *ACSA* antral cross-sectional areaTable 3Ultrasonographic data according to surgery typeSeptoplasty (*n* = 31)SRP (*n* = 44)FESS (*n* = 13)*p*Pre AP diameter (mm)14.81 ± 3.8715.23 ± 3.5314.92 ± 2.840.875Post AP diameter (mm)15.71 ± 4.5519.89 ± 5.9518.23 ± 3.520.004*p*0.0560.00010.016Pre CC diameter (mm)22.71 ± 5.1122.8 ± 5.1223.38 ± 6.060.923Post CC diameter (mm)23.55 ± 6.0128.8 ± 9.1124.23 ± 4.850.01*p*0.1330.00010.688Pre CSA diameter (mm^2^)267.19 ± 102.23274.52 ± 96.33282.47 ± 103.810.890Post CSA diameter (mm^2^)299.22 ± 145.53472.73 ± 260.01353.54 ± 130.360.002*p*0.0660.00010.135Data are presented as the mean ± standard deviation*SRP* septo-rhinoplasty, *ESS* functional endoscopic sinus surgery, *Pre* preoperative, *AP* antero-posterior, *Post* postoperative, *CC* cranio-caudal, *CSA* cross-sectional area

Positive correlations were found between the duration of surgery and the postoperative AP diameter (*r* = 0.380, *p* \< 0.05), postoperative CC diameter (*r* = 0.291, *p* \< 0.05), and postoperative ACSA (*r* = 0.369, *p* \< 0.05).

The incidence and severity of PONV are shown in Table [4](#Tab4){ref-type="table"}.Table 4Incidence and severity of PONV after surgerySurgeryTime after surgery (h)Group 2 (*n* = 44)Group 1 (*n* = 44)*p*Septoplasty (*n* = 31)237.5%Severe15%60%Severe25%Moderate15%Moderate15%0.378Mild7.5%Mild20%418.8%Severe10%60%Severe20%Moderate3.8%Moderate12%0.046Mild5%Mild28%850%Severe10%53.3%Severe8%Moderate15%Moderate14%0.862Mild25%Mild31.3%240%Severe0%13.3%Severe1.3%Moderate0%Moderate2%0.226Mild0%Mild10%SRP (*n* = 44)250%Severe20%50%Severe30%Moderate15%Moderate20%0.762Mild15%Mild10%440%Severe15%41.7%Severe20%Moderate10%Moderate11.7%0.845Mild15%Mild10%825%Severe5%33.3%Severe20%Moderate10%Moderate8.3%0.786Mild10%Mild5%245%Severe0%16.7%Severe6.7%Moderate0%Moderate5%0.461Mild5%Mild5%FESS (*n* = 13)240.9%Severe15%54.5%Severe30%Moderate20%Moderate14.5%0.286Mild5.9%Mild10%429.5%Severe10%47.7%Severe20%Moderate14.5%Moderate19.7%0.126Mild5%Mild5%831.8%Severe16.8%38.6%Severe12%Moderate12%Moderate14%0.655Mild3%Mild10.8%242.3%Severe0%15.9%Severe6%Moderate0%Moderate8%0.064Mild0%Mild1.9%*PONV* postoperative nausea and vomiting, *SRP* seprorhinoplasty, *FESS* functional endoscopic sinus surgery

Discussion {#Sec8}
==========

Pharyngeal packing is commonly performed following a tracheal intubation to reduce PBI and/or tracheal contamination during ear, nose and throat (ENT), and oral surgeries. Pharyngeal packs should absorb blood and provide a physical barrier preventing PBI and reducing the incidence of PONV \[[@CR6]\]. Despite the common belief in the efficacy of PP, it does not offer 100% protection against PBI \[[@CR14]\]. In this study, postoperative gastric diameters and volume were increased in the postoperative period in patients who did and did not receive PP, but were greater in patients not treated with PP. Thus, patients undergoing NS who received PP ingested less blood and secretions into the stomach, than those not treated with PP. This finding is clinically meaningful in two ways. First, the perioperative ingestion of secretions and blood may result in the risk of postoperative pulmonary aspiration due to an increased GV \[[@CR15]--[@CR17]\]. Second, it can increase the incidence of PONV \[[@CR18], [@CR19]\]. Although some researchers have found that PP does not reduce PONV, and that it increases postoperative aphthous stomatitis and sore throat \[[@CR3]\], many anaesthesiologists believe that PP prevents PONV by creating a physical barrier for the entry of blood from the throat into the stomach during NS \[[@CR6], [@CR15]\]. In our study, only patients who underwent septoplasty surgery, PP was decreased PONV incidence and severity at the first four hours, postoperatively.

Van de Putte and Perlas \[[@CR20]\] confirmed the mathematical model for the gastroscopic and ultrasonographic evaluation of GV and published the formula used in this study for the right lateral decubitus position. According to this formula, a GV \< 1.5 ml/kg reflects a low pulmonary aspiration risk \[[@CR21], [@CR22]\]. Arzola et al. \[[@CR23]\] performed bedside a gastric ultrasonographic evaluation after 8 h fasting, with patients with term pregnancies in the right lateral decubitus position prior to an elective caesarean section; they calculated GVs using the above-mentioned formula. In 2011, Bouvet et al. \[[@CR24]\] evaluated correlations between the GV and ACSA obtained by an ultrasonographic measurement with patients in the supine position. They reported preoperative ACSAs of 280 ± 115 mm^2^ and 581 ± 294 mm^2^ in elective and emergent patients, respectively, and proposed a supine ACSA cut-off value of approximately 340 mm^2^ for 0.8 ml/kg GV, which determined the aspiration risk with a sensitivity of 91% and a negative predictive value of 94%. In our study, preoperative ACSAs exceeded this cut-off in 21 of 88 (23.8%) patients. Pharygeal packing in elective NS may prevent the development of GVs carrying a postoperative pulmonary aspiration risk (threshold, 0.8 mL/kg) by 77%. However, the critical cut-off value for GV with regard to an aspiration risk must be discussed. The critical threshold for this risk has been reported to be 0.4--0.8 ml/kg (28--56 ml/70 kg) \[[@CR20], [@CR25]\], but the 0.8 ml/kg threshold is probably insufficient because regurgitation and aspiration of a minimum of 200 ml GV are required for pulmonary damage \[[@CR26]\]. Residual GVs in healthy, hungry patients can be ≥1.5 ml/kg \[[@CR27]\]. The pathophysiology of pulmonary aspiration during general anaesthesia is complex and associated with various risk factors (e.g. difficult airway management, inappropriate anaesthesia technique, straining, coughing, gastro-oesophageal reflux) \[[@CR28]\].

There are some major limitations in this study that could be adressed in future researches. First, there were a few patients in the different nasal surgeries' groups. Second, we did not examine the correlation between GV and PONV. Third, we did not investigate whether the duration of NS increased the GV. Fourth, we did not calculate GV using a confirmed mathematical method developed for use with angles measured in the supine position and antral CSA. Further studies are needed to evaluate the relationship between PP and perioperative pulmonary aspiration risk, and between postoperative GV and PONV. A larger sample size and different nasal surgery population need to be researched for the outcome.

Conclusions {#Sec9}
===========

In conclusion, PP reduces the increase in the perioperative GV due to PBI in elective NS. It prevents the possible aspiration of blood into the aerodigestive tract. Although PP implementation is advantageous for anaesthesiologists, it seems to be disadvantageous for ENT surgeons. Cooperation is needed for this issue. Bedside ultrasound examination can aid such cooperation, enabling a determination of the degree of stomach fullness for anaesthesiologists and ENT surgeons in the operating room. Gastric volume evaluation before extubation plays a very important role, guiding decisions about gastric decompression. An increased GV is a marker of perioperative pulmonary aspiration and PONV risk. We believe that PP is a useful and safe means of reducing the risk of perioperative pulmonary aspiration in NS.
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